KDM6脱甲基酶有助于EWSR1::FLI1驱动的Ewing肉瘤瘤重编程
Elisabet Figuerola-Bou1, Carla Ríos-Astorch1, Enrique Blanco2,3
1Pediatric Cancer, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain.
Cancer research
|October 14, 2025
概括
尤文肉瘤是由EWSR1::FLI1.1驱动的 KDM6A和KDM6B脱甲基酶是关键合作伙伴,KDM6A招募BRG1和KDM6B去除H3K27me3,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 尤文肉瘤是一种骨和软组织癌症,由EWSR1::FLI1蛋白驱动.
- EWSR1::FLI1劫持细胞表观遗传,形成活性增强剂,对瘤生长至关重要.
- 针对EWSR1::FLI1辅因子是一种有前途的治疗策略.
研究的目的:
- 调查H3K27me3脱甲基酶KDM6A和KDM6B在EWSR1::FLI1驱动的转录中的作用.
- 阐明KDM6A和KDM6B在Ewing肉瘤病变发生过程中的特定功能.
主要方法:
- 在人类儿科介质干细胞中,EWSR1::FLI1的表达.
- 对H3K27me3重新分布的全基因组分析.
- 评估KDM6A和KDM6B抑制对基因表达和瘤生长的影响.
主要成果:
- EWSR1::FLI1表达导致了全基因组的H3K27me3重新分配.
- KDM6A独立地将BRG1招募到具有单个GGAA动机的增强剂中,这对瘤生长至关重要.
- 在特定的增强剂中,KDM6B去甲基化了H3K27me3,在GGAA重复时与BRG1同位,其损失损害了瘤异种移植的生长.
结论:
- KDM6A和KDM6B是EWSR1::FLI1.1的关键功能合作伙伴.
- 这些KDM6脱甲基酶在调节EWSR1::FLI1转录活性方面表现出不同的作用.
- KDM6脱甲基酶代表了Ewing肉瘤治疗的潜在治疗点.
相关概念视频
01:24Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K